Trademark applications and grants for Aventis Pharmaceuticals Inc. Aventis Pharmaceuticals Inc has 60 trademark applications. The latest application filed is for "NASACORT HFA"
Patent Application | Date |
---|---|
PHARMACEUTICAL COMPOSITION COMPRISING FEXOFENADINE 20140073670 - 14/082415 BADABHAGNI; Sudhakara Rao ;   et al. | 2014-03-13 |
METHOD FOR REDUCING CARDIOVASCULAR MORBIDITY AND MORTALITY IN PREDIAETIC PATIENTS AND PATIENTS WITH TYPE 2 DIABETES 20130012433 - 13/617341 ROSSKAMP; Ralf ;   et al. | 2013-01-10 |
SUBSTITUTED PYRIMIDINE AS A PROSTAGLANDIN D2 RECEPTOR ANTAGONIST 20130005741 - 13/610005 HARRIS; Keith John ;   et al. | 2013-01-03 |
SUBSTITUTED PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS 20130005728 - 13/610027 HARRIS; Keith J. ;   et al. | 2013-01-03 |
SUBSTITUTED PROPANE PHOSPHINIC ACID DERIVATIVES 20120208784 - 13/454643 CHOI-SLEDESKI; Yong Mi ;   et al. | 2012-08-16 |
SEC | 0001267093 | AVENTIS PHARMACEUTICALS INC |
SEC | 0000062391 | AVENTIS PHARMACEUTICALS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.